By Shay Castle - Nov. 26, 2024

California dreamin’?

The complicated role of cannabis in the recovery community

By Shay Castle - Nov. 13, 2024

Psychedelic system of record

Three questions for Boulder-based software company Althea

By Shay Castle - Nov. 6, 2024

Why is the DEA trying to ban these research chemicals?

Psychedelic researchers decry feds attempt to schedule DOI and DOC

By Niko Skievaski - Oct. 22, 2024

Live from PsyCon

Colorado preps for legal shroom-assisted therapy

By Shay Castle - Oct. 9, 2024

Who Colorado’s cannabis industry is backing in Election 2024

Marijuana Industry Group debuts statewide "Green Voter Guide"

By Shay Castle - Sep. 10, 2024

Hugs and drugs

A psychedelic painter on the power of ’shrooms and taking the art form seriously

By Shay Castle - Aug. 27, 2024

‘Bound to fail’

Ongoing CU study reveals BIPOC fears about legal psychedelics

By Niko Skievaski - Aug. 14, 2024

Feds deny MDMA

FDA rejects first application for drug-assisted therapy despite 71% efficacy

By Niko Skievaski - Jul. 31, 2024

Psychedelics: Can we call it an industry?

There are a lot of mixed feelings about bringing psychedelics into the land of American capitalism. Users often say these medicines can evoke feelings of oneness, unity, love — directionally...

By Shay Castle - Jul. 16, 2024

The pot blind spot

T, a student at a Colorado medical school, can count on one hand the things she’s learned about cannabis and psychedelics from her professors. “We’ve had probably two hour-and-a-half lectures...

By Shay Castle - Jun. 12, 2024

Gray matter

“Under Colorado law, I cannot sell you psilocybin,” an employee tells the crowd gathered at the Mad Hatter booth. “If you buy a sticker, I can gift you some product....

By Kaylee Harter - May 1, 2024

Green flags

As the state works on finalizing its rules for psilocybin facilitator training, three educators weigh in on questions to ask and red flags to look out for in a potential...